Below are the most recent publications written about "Asthma" by people in Profiles.
-
Grunwell JR, Fitzpatrick AM. Asthma Phenotypes and Biomarkers. Respir Care. 2025 06; 70(6):649-674.
-
Gold DR, Carey VJ, Hersh CP, Wan E, Camargo CA, Lee IM, Cook NR, Nassikas N, Buring JE, Manson JE, Luttmann-Gibson H. Vitamin D Supplementation, Chronic Obstructive Lung Disease and Asthma Exacerbations, and Lung Function Decline. J Nutr. 2025 May; 155(5):1417-1428.
-
Skolnik N, Yawn BP, Correia de Sousa J, V?zquez MMM, Barnard A, Wright WL, Ulrich A, Winders T, Brunton S. Best practice advice for asthma exacerbation prevention and management in primary care: an international expert consensus. NPJ Prim Care Respir Med. 2024 Nov 17; 34(1):39.
-
G?mez LF, Kinnee E, Kaufman JD, Young MT, Fitzpatrick AM, Phipatanakul W, Mauger DT, McClure LA, Bilal U, Holguin F, Clougherty JE. Modification of asthma treatment efficacy by healthcare access: A reanalysis of AsthmaNet Step-Up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS) clinical trial. Respir Med. 2024 Nov-Dec; 234:107853.
-
Levy ML, Kocks JWH, Bosnic-Anticevich S, Safioti G, Reich M, Depietro M, Castro M, Farooqui N, Lugogo NL, Brown R, Hill T, Li T, Chrystyn H. Uncovering patterns of inhaler technique and reliever use: the value of objective, personalized data from a digital inhaler. NPJ Prim Care Respir Med. 2024 08 20; 34(1):23.
-
Fitzpatrick AM, Mohammad AF, Desher K, Mutic AD, Stephenson ST, Dallalio GA, Grunwell JR. Clinical and inflammatory features of traffic-related diesel exposure in children with asthma. Ann Allergy Asthma Immunol. 2024 Oct; 133(4):393-402.e4.
-
Harris D, Borish L. How we treat type 2 low asthma. Ann Allergy Asthma Immunol. 2024 Jul; 133(1):43-46.
-
Vukoja M, Tekin A, Parada NA, Gray JC, Mallouhi A, Roddy T, Cartin-Ceba R, Perkins NE, Belden KA, Cheruku S, Kaufman M, Lee Armaignac D, Christie AB, Lal A, Zu Y, Kumar V, Walkey A, Gajic O, Kashyap R, Denson JL. The Association of Asthma and Metabolic Dysfunction With Outcomes of Hospitalized Patients With COVID-19. J Allergy Clin Immunol Pract. 2024 Sep; 12(9):2390-2398.e7.
-
Hernandez-Lara MA, Richard J, Deshpande DA. Diacylglycerol kinase is a keystone regulator of signaling relevant to the pathophysiology of asthma. Am J Physiol Lung Cell Mol Physiol. 2024 Jul 01; 327(1):L3-L18.
-
Skolnik N, Mahler DA, Yawn BP. Airflow Reversibility in Patients With Asthma. Am Fam Physician. 2024 04; 109(4):298-300.